Home     Program     Faculty     Registration     Accommodation
     Home
     Welcome Note
     Conference Chairpersons
     Faculty List
         Guidelines for Speakers
     Program
     Timetable
     Abstract Poster Presentations
         Posters Presentation Guide
     General Information
         Your arrival to Munich
         Tips and Hints
         Italian Agent
         Chinese Agent
     CME
     Registration
         Invitation Letter
     Accommodation
     Sponsorship & Exhibition
         Sponsors
         Sponsorship Disclosure
     Partners
     Previous Conference
         CoVAC 2011
     About Munich
     Contact Us
  

 
  Program Print
Thursday, February 14, 2013
19:00-20:00
WELCOME RECEPTION

 
20:00-20:30
Opening Remarks
Conference Co-Chairpersons:
E. Rubinstein, Canada & H. Lode, Germany


20:30-21:30
SPECIAL GUEST LECTURE
Global evolution of the Pneumococcus and the impact of vaccination
K. Klugman, USA

Friday, February 15, 2013
08:30–08:45
Opening Address
T. Welte, Germany
President of the German Respiratory Society
 
Session 1
08:45-10:45
PNEUMOCOCCAL VACCINE
Chairperson: J. Garau, Spain
08:45–09:45
Debate: Do we need the pneumococcal polysaccharide vaccine any more?
Pro: R. Dagan, Israel
Con: M. Pletz, Germany


09:45–10:45
Debate: Pneumococcal vaccine efficacy. Do we need only antibody responses or additional markers?
Pro: R.R. Reinert, Germany
Con: D. Goldblatt, UK

10:45– 11:15 Coffee Break

 
Session 1 (continued)
11:15– 12:15
ROUND TABLE DISCUSSION
Optimizing pneumococcal vaccination
Chairperson: T. Welte, Germany


Discussants:
J. Garau, S
pain
R.R. Reinert, Germany
D. Goldblatt, UK
R. Dagan, Israel
 
Questions
Optimal timing?
Optimal age?
Costs?
Acceptance?

12:15–13:15 Buffet Lunch

Parallel Sessions
HALL A
Session 2a
13:15-14:15
INFLUENZA VACCINES
Chairperson: W. Doerr, Germany
13:15–14:15
Debate: Should we continue seasonal influenza vaccination or should we wait for better vaccines?
Pro: A Örtqvist, Sweden
Con: A. Banzhoff, Germany
 
HALL B
Session 2b
13:15-14:15
Moderator: H. Lode, Germany
13:15-13:30
 
 
 
Predictors of hepatitis B vaccine acceptance among Nigerian primary health care workers
I.S. Abdulraheem, Nigeria
 
13:30-13:45
 
 
 
Getting nurses that immunize infants to receive the pertussis vaccine, a circular feedback intervention
O. Baron-Epel, Israel
 
13:45-14:00
 
 
 
Since vaccination with Gardasil® and Cervarix® HPV 11 and 16 prevalence already decreased in women younger than 25 yrs
C.E. Depuydt, Belgium
 
14:00-14:15
 
 
 
The willingness of elderly to be vaccinated:Insight in their motives
R.R. Eilers, The Netherlands
 
 
 
HALL A
Session 3a
14:15– 16:15
14:15–15:15
Debate: Human Papillomavirus for young male adults?
Chairperson: P. Hillemanns, Germany
Pro: F.X. Bosch, Spain
Con:Y. Deleré, Germany


15:15–16:15
Debate: Vaccination in travel medicine. Should immunocompromized patients be vaccinated?
Chairperson: T. Löscher, Germany
Pro: T. Jelinek, Germany
Con: R. Steffen, Switzerland
 
HALL B
Session 3b
14:15– 16:15
Moderators: S. Bhakdi, Germany; E. Rubinstein, Canada 
14:15-14:30
 
 
 
A novel multi-antigen vaccine to prevent Staphylococcus aureus infection and disease-Can we beat the bug at its own game?
A.S. Anderson, USA
 
14:30-14:45
 
 
 
Factors associated with incident diagnoses of herpes zoster in a large prospective cohort of older adults
B. Liu, Australia
 
14:45-15:00
 
 
 
Pan-surfomic analysis of pneumococcal clinical isolates from adults: identification of potential protein vaccine candidates
A. Olaya-Abril, Spain
 
15:00-15:15
 
 
Invasive pneumococcal diseases in Pilsen Region (Czech Republic)
P. Pazdiora, Czech Republic
 
15:15-15:30
 
 
 
Pneumococcal disease and new recommendation for adult immunization in the Czech Republic
R. Prymula, Czech Republic
 
15:30-15:45
 
 
 
Proliferative responses to live pneumococci are reduced in older compared to young adults
N.D. Ritchie, UK
 
15:45-16:00
 
 
 
Abnormal repertoire development in common variable immune deficiency and recurrent sinopulmonary infection
H.W. Schroeder, USA
 
16:00-16:15
 
 
 
Cytomegalovirus-associated accumulation of late-differentiated CD4 T-cells correlates with poor antibody response to influenza vaccination
H.M. Theeten, Belgium
 
16:15-16:45 Coffee Break

Session 4
16:45-17:45
VZV VACCINE

Debate: Progress in VZV vaccine?
Chairperson: P. Wutzler, Germany
Pro M. Oxman, USA
Con: W. Doerr, Germany

Saturday, February 16, 2013
08:30–09:15
SPECIAL GUEST LECTURE
Chairperson: H. Lode, Germany
Emerging pathogens and vaccine development
A. Osterhaus, The Netherlands

Session 5
09:15-11:15
HIV VACCINE AND C. DIFFICILE VACCINE
09:15-10:15
Debate: Any progress in HIV vaccine?
Chairperson:  H.W. Doerr, Germany
Pro: J. Kim, USA
Con: L. Gürtler, Germany


10:15-11:15
Debate: Can we prevent C difficile infections by vaccines?
Chairperson: A. Rodloff, Germany
Pro: D. Gerding, USA
Con: L. von MüllerGermany
11:15–11:45 Coffee Break

Session 5 (continued)
11:45–12:30
ROUND TABLE DISCUSSION
How to prevent C. difficile colonization and infection?
Chairperson: E. Rubinstein, Canada
 
 
Discussants:
A. Rodloff, Germany
G. Peters, Germany
D. Gerding, USA
L. von Müller,Germany
 
Questions:
What vaccines are there in phase II & III to prevent C.difficile?
What is the role of probiotics in preventing C difficile diarrhea?
What is the role of manipulation of the microbiome in preventing C difficile diarrhea?
Can the microbiome forcast who will get C difficile diarrhea?
Are there any genetic markers that will forcast who will get C difficile diarrhea?

12:30–13:30 Buffet Lunch
 
Session 6
13:30–15:30
STAPHYLOCOCCAL VACCINE AND TB VACCINE
13:30–14:30
Debate: Prevention of Staphylococcal infections by vaccines?
Chairperson: G. Peters, Germany
Pro: A.S. Anderson,
USA
Con: J. Lee, USA


14:30–15:30
Debate: TB vaccine – any progress?
Chairperson: H. Lode, Germany
Pro: T.M. Doherty, Denmark
Con: TB vaccines: controversies and obstacles: T. Ottenhoff, The Netherlands 

15:30–16:00 Coffee Break
 
Session 7
16:00-17:45
VACCINATION AGAINST ATHEROSCLEROSIS AND SMOKING
16:00–17:00
Debate: Vaccination and atherosclerosis – any scientific and clinical impact?
Chairperson: T. Welte, Germany
Pro: A. Örtqvist, Sweden
Con: S. Bhakdi, Germany
   
17:00–17:45
Pros and cons of Vaccination against smoking
Chairperson: E. Rubinstein, Canada
Lecture: T. Raupach, Germany
Discussion

Session 8
17:45-18:45
Chairpersons: J. Garau, Spain; H. Lode, Germany
 

ROUND TABLE DISCUSSION
Healthy aging and health personnel – What is the position and acceptance of vaccines?
 
Discussants:
B. Velan, Israel
R. Dagan, Israel
A. McGeer, Canada
A. Örtqvist, Sweden
R.R. Reinert, Germany
 
18:45
Conference Summary
E. Rubinstein, Canada

Sunday, February 17, 2013

Travel Day


Home    Invitation Letter    Registration    Contact Us   
Copyright © 2007 comtecmed.com. All rights reserved.   The website was last updated on 02/18/2013 Created by     WebStudio.co.il